KR930023369A - 면역원성 포합체 및 그의 제조방법 - Google Patents
면역원성 포합체 및 그의 제조방법 Download PDFInfo
- Publication number
- KR930023369A KR930023369A KR1019930007776A KR930007776A KR930023369A KR 930023369 A KR930023369 A KR 930023369A KR 1019930007776 A KR1019930007776 A KR 1019930007776A KR 930007776 A KR930007776 A KR 930007776A KR 930023369 A KR930023369 A KR 930023369A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- phosphate
- reacting
- carrier protein
- allyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
세균 내독소로 가인되는 부패속의 예방을 위해 백신에서 사용하기 위한 일반식
의 합성 당포합체 항원 및 상기 당포합체의 제조방법.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 다음 일반식의 부패속 치료를 위한 면역원성 포합체 :식에서 P1은 수소 또는 인산염이고; R2는 알킬(C1-C4)이고; P2는 수소, 프로필, 알릴 또는 인산염이고; n은 1-30의 정수이고; Q는 운반 단백질 또는 펩티드이다.
- 제 1항에 있어서, 운반 단백질 또는 펩티드는 CRM197, CRM197로 부터 유래된 펩티드, 디프테리아 톡소이드, 파상풍 톡소이드 및 디프테리아 또는 파상풍 톡소이드로 부터 유래된 펩티드로 부터 선택되는 면역원성 포함체.
- 다음 일반식의 화합물 :식에서 R1은 수소 또는 아실이고; R2는 (C1-C4) 알킬이고; R3는 수소 또는 CH(CH2)4COOX이고, 이때 X는 식의 성분이고; P1은 수소 또는 인산염이고 P2는 수소, 프로필, 알릴 또는 인산염이다.
- (i) 다음 일반식의 화합물 :(이때 R1은 수소 또는 아실이고, R2는 알킬 (C1-C4)이고, P1은 수소 또는 인산염이고 P2는 수소, 프로필, 알릴 또는 인산염이다)을 하나는 상기 화합물의 일차아민과 반응할 수 있고 다른 하나는 운반 단배길과 반응할 수 있는 2개의 관능기를 포함하느 분자와 반응시키고 (ⅱ) (ⅰ)의 생성물은 상기 운반 단백질과 반응시켜 포함이 일어나게 함으로 구성되는 면역원성 포합체의 제조방법.
- 제 4항에 있어서, 단계 (ⅰ)의 2개의 관능기를 포함하는 분자는 디에스테르인 방법.
- 제 4항에 있어서, 단계 (ⅰ)의 2개의 관능기를 포함하는 분자는 아디프산의 디에스테르 도는 숙신산의 디에스테르인 방법.
- 다음 단계들로 구성되는 방법으로 제조되는 D-글루코사민 이당류와 운반 단백질간의 공유 포합체 : (ⅰ) 다음 일반식의 화합물 :(이 때 R1은 수소 또느 아실이고, R2는 알킬(C1-C4)이고, P1은 수소 또는 인산염이고 P2는 수소, 프로필, 알릴 또는 인산염이다)을 하나는 활성화 이당류의 말단기와 반응할 수 있고 다른 하나는 상기 운반 단백질과 반응 할 수 있는 2개의 관능기를 포함하는 분자와 반응시켜 활성화 D-글루코사민 이당류를 제조하는 단계; 및 (ⅱ) (ⅰ)의 활성화 D-글루코사민 이당류 생성물을 상기 운반 단백질과 반응시켜 포함이 일어나게 하는 단계.
- 제 7항의 공유 포합체를 포함하는 부패속의 예방을 위한 백신.
- 제 7항에 따라 제조된 공유 포합체를 포함하는 부패속의 예방을 위한 백신.
- 다음 일반식의 화합물 :식에서 Bn은 벤질이고, P3은 인산염 또는 인산 디페닐이고, P4는 알릴 또는 프로필 또는 수소 또는 인산 디벤질이고, Ac는 아실이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87940392A | 1992-05-07 | 1992-05-07 | |
US7/879,403 | 1992-05-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR930023369A true KR930023369A (ko) | 1993-12-18 |
Family
ID=25374087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930007776A KR930023369A (ko) | 1992-05-07 | 1993-05-06 | 면역원성 포합체 및 그의 제조방법 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0570682B1 (ko) |
JP (1) | JPH0641200A (ko) |
KR (1) | KR930023369A (ko) |
AT (1) | ATE155790T1 (ko) |
AU (1) | AU664609B2 (ko) |
CA (1) | CA2095588A1 (ko) |
DE (1) | DE69312391T2 (ko) |
DK (1) | DK0570682T3 (ko) |
ES (1) | ES2104984T3 (ko) |
FI (1) | FI932053A (ko) |
GR (1) | GR3024706T3 (ko) |
IL (1) | IL105605A0 (ko) |
NO (1) | NO180234C (ko) |
SG (1) | SG47582A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214256A (ja) * | 2007-03-02 | 2008-09-18 | Yaizu Suisankagaku Industry Co Ltd | 双頭型配糖化合物の製造方法及び双頭型配糖化合物並びに該双頭型配糖化合物を含有する糖鎖認識タンパク質結合剤 |
CA2736134A1 (en) * | 2008-09-05 | 2010-03-11 | National Research Council Of Canada | Lps based vaccines |
WO2017173024A1 (en) | 2016-03-30 | 2017-10-05 | AyuVis Research LLC | Novel compositions and therapeutic methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1187753B (it) * | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
AU651319B2 (en) * | 1989-07-27 | 1994-07-21 | Univax Biologics Incorporated | Lipid A analog/immunogenic carrier conjugates and the use thereof as vaccines |
-
1993
- 1993-03-17 SG SG1996002942A patent/SG47582A1/en unknown
- 1993-03-17 EP EP93104369A patent/EP0570682B1/en not_active Expired - Lifetime
- 1993-03-17 DK DK93104369.9T patent/DK0570682T3/da active
- 1993-03-17 DE DE69312391T patent/DE69312391T2/de not_active Expired - Fee Related
- 1993-03-17 AT AT93104369T patent/ATE155790T1/de active
- 1993-03-17 ES ES93104369T patent/ES2104984T3/es not_active Expired - Lifetime
- 1993-05-04 IL IL105605A patent/IL105605A0/xx unknown
- 1993-05-05 CA CA002095588A patent/CA2095588A1/en not_active Abandoned
- 1993-05-06 AU AU38419/93A patent/AU664609B2/en not_active Ceased
- 1993-05-06 JP JP5129939A patent/JPH0641200A/ja active Pending
- 1993-05-06 NO NO931655A patent/NO180234C/no unknown
- 1993-05-06 FI FI932053A patent/FI932053A/fi not_active Application Discontinuation
- 1993-05-06 KR KR1019930007776A patent/KR930023369A/ko not_active Application Discontinuation
-
1997
- 1997-09-11 GR GR970402350T patent/GR3024706T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0570682A1 (en) | 1993-11-24 |
IL105605A0 (en) | 1993-09-22 |
ATE155790T1 (de) | 1997-08-15 |
NO180234C (no) | 1997-03-12 |
NO180234B (no) | 1996-12-02 |
FI932053A (fi) | 1993-11-08 |
AU3841993A (en) | 1993-11-11 |
FI932053A0 (fi) | 1993-05-06 |
DE69312391D1 (de) | 1997-08-28 |
DK0570682T3 (da) | 1998-02-16 |
DE69312391T2 (de) | 1997-12-11 |
JPH0641200A (ja) | 1994-02-15 |
NO931655L (no) | 1993-11-08 |
GR3024706T3 (en) | 1997-12-31 |
AU664609B2 (en) | 1995-11-23 |
NO931655D0 (no) | 1993-05-06 |
CA2095588A1 (en) | 1993-11-08 |
ES2104984T3 (es) | 1997-10-16 |
SG47582A1 (en) | 1998-04-17 |
EP0570682B1 (en) | 1997-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0208375B1 (en) | Glycoproteinic conjugates having trivalent immunogenic activity | |
FI79024B (fi) | Foerfarande foer framstaellning av haemophilus influenzae b-polysackaridexotoxoidkonjugatvaccin. | |
DE69620271T2 (de) | Polyribosylribitol-phosphat enthaltende Haemophilus-influenzae-Typ-b-Impfstoffzubereitung und Verfahren zur deren Herstellung | |
KR880007557A (ko) | 신규의 올리고 당류, 면역원 및 백신 그리고 그들의 제조방법 | |
AU589501B2 (en) | Fuel composition | |
DK0497524T3 (da) | Polysaccharid-antigener fra Streptococcus pneumoniae | |
WO1990004918A3 (en) | Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions | |
US4771127A (en) | Nontoxic pseudomonas aeruginosa polysaccharide-tetanus toxoid and polysaccharide-toxin a conjugate vaccines | |
Ajl et al. | STUDIES ON PLAGUE: I. Purification and Properties of the Toxin of Pasteurella pestis | |
KR930023369A (ko) | 면역원성 포합체 및 그의 제조방법 | |
KR890009963A (ko) | 신규한 폴리사카라이드와 그 폴리사카라이드의 신규한 고분자 결합체 및 그를 포함하는 왁진과 그들의 제조방법 | |
ES2052803T3 (es) | Composicion alergenica liquida, fisiologicamente activa obtenida de materias primas biologicas y el correspondiente proceso de preparacion. | |
KR930703264A (ko) | 신규한 필로카르핀 유도체 및 그것의 제조방법 | |
GR3005183T3 (ko) | ||
KR880011071A (ko) | 신규한 알킬 알카노에이트, 그의 제조방법 및 백신에 있어서 그의 에스테르의 수성 유액의 용도 | |
KR910018371A (ko) | 이소크로메인 유도체 | |
PT87001A (pt) | Processo para a preparacao de uma vacina contra a disenteria suina e fins analogos | |
KR890009896A (ko) | 디옥사조신 유도체, 그의 제법 및 그를 함유하는 조성물 | |
KR910011857A (ko) | 2-푸릴퓨린 유도체의 제조방법 | |
KR930000528A (ko) | 아미노피롤리딘 백금화합물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |